Comgest Global Investors S.A.S. Has $36.58 Million Position in Stryker Corporation $SYK

Comgest Global Investors S.A.S. increased its holdings in shares of Stryker Corporation (NYSE:SYK) by 16.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 98,944 shares of the medical technology company’s stock after buying an additional 13,806 shares during the period. Stryker accounts for about 0.6% of Comgest Global Investors S.A.S.’s investment portfolio, making the stock its 27th biggest holding. Comgest Global Investors S.A.S.’s holdings in Stryker were worth $36,577,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Clayton Financial Group LLC bought a new stake in Stryker in the 3rd quarter valued at approximately $26,000. Elevation Point Wealth Partners LLC acquired a new position in Stryker during the second quarter worth approximately $28,000. Kilter Group LLC bought a new stake in Stryker in the 2nd quarter valued at $29,000. Howard Hughes Medical Institute acquired a new stake in shares of Stryker during the 2nd quarter worth about $29,000. Finally, MTM Investment Management LLC bought a new stake in shares of Stryker during the second quarter worth approximately $38,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Insiders Place Their Bets

In other news, Director Ronda E. Stryker sold 250,000 shares of Stryker stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the sale, the director directly owned 2,457,331 shares of the company’s stock, valued at approximately $891,814,566.52. The trade was a 9.23% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 5.90% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research firms have issued reports on SYK. Raymond James Financial raised shares of Stryker from a “market perform” rating to an “outperform” rating and set a $418.00 price objective for the company in a report on Tuesday, January 6th. Barclays reiterated an “overweight” rating and set a $469.00 price objective on shares of Stryker in a research report on Monday, February 2nd. Wall Street Zen cut Stryker from a “buy” rating to a “hold” rating in a report on Saturday, January 31st. Citigroup restated a “market outperform” rating on shares of Stryker in a report on Friday, January 30th. Finally, Sanford C. Bernstein upped their price objective on shares of Stryker from $450.00 to $465.00 and gave the company an “outperform” rating in a research note on Friday, January 9th. Twelve research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $426.94.

Stryker Trading Up 2.1%

NYSE SYK opened at $377.08 on Thursday. The stock has a market capitalization of $144.30 billion, a price-to-earnings ratio of 44.89, a PEG ratio of 2.16 and a beta of 0.87. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.89 and a quick ratio of 1.21. Stryker Corporation has a one year low of $329.16 and a one year high of $404.87. The business’s fifty day moving average is $359.13 and its 200-day moving average is $368.93.

Stryker (NYSE:SYK) last issued its earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.40 by $0.07. The firm had revenue of $7.17 billion for the quarter, compared to analyst estimates of $7.12 billion. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The business’s revenue was up 11.4% on a year-over-year basis. During the same period in the previous year, the company posted $4.01 earnings per share. Equities research analysts predict that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be paid a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 annualized dividend and a yield of 0.9%. Stryker’s dividend payout ratio (DPR) is currently 41.90%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.